Health
newsGP – AstraZeneca’s lower efficacy has been questioned, but what about other considerations? – RACGP
Experts weigh in on whether greater investment in candidates with a higher efficacy rate would actually provide greater promise of elimination.
News
Experts weigh in on whether greater investment in candidates with a higher efficacy rate would actually provide greater promise of elimination.
The spotlight is on AstraZenecas candidate, co-developed with the University of Oxford, as Australia moves closer to its mid-February vaccine rollout.
As the US, UK and Europe continue to record thousands of daily new cases of COVID-19, it has been said time again that Australia is in an enviable position.The vaccine roadmap is expected to begin with…
-
Noosa News23 hours agoEastern states shivered through a chilly June, is a warmer winter still on the cards?
-
Noosa News22 hours agoHow a 3D printed aorta helped surgeons replace a ‘ticking time bomb’ inside a man’s chest
-
Noosa News19 hours agoEnsure voices are heard – Proctor
-
Noosa News21 hours agoCity of Moreton Bay claims homeless people consented to having camps thrown away